Literature DB >> 19073657

Hermann Senator and albuminuria--forgotten pioneering work in the 19th century.

Ron T Gansevoort1, Eberhard Ritz.   

Abstract

Testing urinary albumin concentration by immune detection methods has recently turned out to be a highly rewarding procedure, as low level albumin excretion has turned out to be a powerful predictor of cardiovascular and renal risk in diabetic and nondiabetic patients. In the following we discuss a text dating back to the 19th century in order to make today's nephrologists aware of the remarkable and prescient, but meanwhile completely forgotten investigations on urinary albumin excretion in individuals without primary kidney disease. The treatise of Hermann Senator convincingly disproved the then held dogma that albuminuria was always a sign of primary renal disease. These observations are all the more remarkable since he was forced to use relatively simple and not absolutely specific methods. He further provided an explanation of the renal handling of albumin which to a large extent is still valid today.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073657     DOI: 10.1093/ndt/gfn741

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

Review 1.  Albuminuria Is an Appropriate Therapeutic Target in Patients with CKD: The Pro View.

Authors:  Hiddo J Lambers Heerspink; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-17       Impact factor: 8.237

Review 2.  Limitations and future treatment options in type 2 diabetes with renal impairment.

Authors:  Eberhard Ritz
Journal:  Diabetes Care       Date:  2011-05       Impact factor: 19.112

Review 3.  The Potential of Albuminuria as a Biomarker of Diabetic Complications.

Authors:  Pappitha Raja; Alexander P Maxwell; Derek P Brazil
Journal:  Cardiovasc Drugs Ther       Date:  2020-07-17       Impact factor: 3.727

Review 4.  Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease.

Authors:  Michelle J Pena; Harald Mischak; Hiddo J L Heerspink
Journal:  Diabetologia       Date:  2016-06-25       Impact factor: 10.122

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.